EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Interest Expenses (2018 - 2024)

EyePoint (EYPT) posted Interest Expenses of $32.9 million for Q1 2026, up 1332.32% sequentially from -$2.7 million in Q4 2025, and up 846.33% YoY from $3.5 million in Q1 2025.

Analysis

EyePoint (EYPT) Interest Expenses (2018 - 2024) Analysis & Trends

EyePoint has reported Interest Expenses for 16 years, with the latest figure at $32.9 million in Q1 2026.

  • Quarterly Interest Expenses rose 846.33% year-over-year to $32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.9 million (up 846.33% YoY) and the FY2025 annual result came in at $73.2 million, up 878.44% from the prior year.
  • Interest Expenses climbed to $32.9 million in Q1 2026 per EYPT's latest filing, from -$2.7 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $72.4 million in Q2 2022 and troughed at -$2.7 million in Q4 2025.
  • A 5-year average of $27.0 million and a median of $12.3 million in 2023 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2024 and 2025: Interest Expenses surged 7872.91% in 2024, then plunged 481.0% in 2025.
  • Over 5 years, Interest Expenses stood at $693000.0 in 2022, then retreated by 6.64% to $647000.0 in 2023, then climbed by 8.19% to $700000.0 in 2024, then slumped by 481.0% to -$2.7 million in 2025, then jumped by 1332.32% to $32.9 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $32.9 million, -$2.7 million, and $45.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 14,000.00
Jun 30, 2023 435,000.00
Mar 31, 2023 812,000.00
Dec 31, 2022 781,000.00
Sep 30, 2022 662,000.00
Jun 30, 2022 552,000.00
Mar 31, 2022 1.19 Mn
Dec 31, 2021 1.39 Mn
Sep 30, 2021 1.39 Mn
Jun 30, 2021 1.38 Mn
Mar 31, 2021 1.35 Mn
Dec 31, 2020 1.83 Mn
Sep 30, 2020 1.84 Mn
Jun 30, 2020 1.81 Mn
Mar 31, 2020 1.78 Mn
Dec 31, 2019 1.79 Mn
Sep 30, 2019 1.77 Mn
Jun 30, 2019 1.60 Mn
Mar 31, 2019 1.02 Mn
Dec 31, 2018 1.64 Mn